Items where Author is "Karimi, J."
 | Up a level |
(2022) Impact of miRNA-binding site polymorphisms in STAT3 gene on occurrence and clinical characteristics of systemic lupus erythematosus. LUPUS. pp. 338-346. ISSN 0961-2033 1477-0962 J9 - LUPUS
(2020) Protective effects of combined Losartan and Nilotinib on carbon tetrachloride (CCl4)-induced liver fibrosis in rats. Drug and Chemical Toxicology. pp. 468-478. ISSN 0148-0545
(2020) SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial. Clinical Infectious Diseases. pp. 2206-2212. ISSN 1058-4838
(2018) MiR-185 enhances radiosensitivity of colorectal cancer cells by targeting IGF1R and IGF2. Biomedicine & Pharmacotherapy. pp. 763-769. ISSN 0753-3322
(2018) Protective effects of combined Losartan and Nilotinib on carbon tetrachloride (CCl4)-induced liver fibrosis in rats. Drug Chem Toxicol. pp. 1-11. ISSN 1525-6014 (Electronic) 0148-0545 (Linking)
(2018) SD1000: 96.4 SVR12 in 1237 patients with hepatitis C genotypes 1, 2, 3, 4 using co-formulated sofosbuvir/daclatasvir tablets manufactured in Iran - a multicenter phase 3 clinical trial including HIV co-infected, transplant, and hemodialysis patients. Journal of Viral Hepatitis. pp. 198-199. ISSN 1352-0504